See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Actan, Fluxene, Lorien, Lovan, Prozac, Prozac Weekly, Tuneluz
What is Fluoxetine? Fluoxetine is an antidepressant in a group of drugs called selective serotonin reuptake inhibitors (SSRIs). Fluoxetine affects chemicals in the brain that may become unbalanced and cause depression, panic, anxiety, or obsessive-compulsive symptoms.
See more information, including instructions, precautions, side effects, and interactions.
720 patients in the community are taking or have taken Fluoxetine.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Depression | 257 | 35% |
| Treat my mood condition(s) | 185 | 25% |
| Other | 92 | 12% |
| General health | 16 | 2% |
| Fatigue | 16 | 2% |
| Emotional lability | 11 | 1% |
| Mood swings | 10 | 1% |
| Major Depression | 8 | 1% |
| Fibromyalgia | 7 | <1% |
| Anxiety | 7 | <1% |
| Support another treatment | 6 | <1% |
| disease-related symptoms | 3 | <1% |
| Don't know | 2 | <1% |
| Pain | 2 | <1% |
| ocd | 2 | <1% |
| Treat Parkinson's | 2 | <1% |
| Despair | 1 | <1% |
| extreme anger | 1 | <1% |
| Severe major depression | 1 | <1% |
| Stiffness/spasticity | 1 | <1% |
| none | 1 | <1% |
| PMS | 1 | <1% |
| Excess saliva | 1 | <1% |
| Muscle tension | 1 | <1% |
| Back pain | 1 | <1% |
| Social Anxiety | 1 | <1% |
| Panic attack(s) | 1 | <1% |
| Slow my MS progress | 1 | <1% |
| Slow my ALS progress | 1 | <1% |
How long current patients have been taking Fluoxetine or how long patients were taking Fluoxetine before stopping.
Results from 84 patient evaluations. See the overall results and all individual evaluations.
| Major | 42% | 14 |
|---|---|---|
| Moderate | 36% | 12 |
| Slight | 15% | 5 |
| Can't tell | 6% | 2 |
Depression
| Severe | 10% | 8 |
|---|---|---|
| Moderate | 12% | 10 |
| Mild | 32% | 27 |
| None | 46% | 39 |
Top reported side-effects include: Sexual Side Effects, Emotional Numbness, Sexual dysfunction
Summary results are based on 84 individual responses. For more information, see overall results for Adherence, Burden and Cost.